Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycoplasma | 2 | 2024 | 2 | 0.360 |
Why?
|
| HIV-1 | 6 | 2021 | 755 | 0.350 |
Why?
|
| Bacterial Proteins | 2 | 2024 | 595 | 0.250 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2024 | 57 | 0.240 |
Why?
|
| Mycoplasma Infections | 2 | 2023 | 6 | 0.240 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2024 | 1 | 0.210 |
Why?
|
| Presynaptic Terminals | 1 | 2024 | 54 | 0.210 |
Why?
|
| DNA Copy Number Variations | 1 | 2023 | 37 | 0.200 |
Why?
|
| AIDS-Associated Nephropathy | 2 | 2016 | 14 | 0.170 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 59 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 83 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 70 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 165 | 0.130 |
Why?
|
| Dopamine | 1 | 2019 | 275 | 0.130 |
Why?
|
| HIV Infections | 3 | 2021 | 2586 | 0.130 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 486 | 0.130 |
Why?
|
| Oxidative Stress | 2 | 2019 | 1003 | 0.120 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2016 | 113 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2014 | 6 | 0.110 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2014 | 31 | 0.110 |
Why?
|
| Animals | 10 | 2024 | 16992 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 92 | 0.100 |
Why?
|
| Neoplasms | 1 | 2024 | 1377 | 0.100 |
Why?
|
| Rats, Transgenic | 3 | 2019 | 34 | 0.100 |
Why?
|
| Mycoplasma fermentans | 2 | 2023 | 2 | 0.090 |
Why?
|
| Mice | 4 | 2024 | 6644 | 0.080 |
Why?
|
| Brain | 2 | 2016 | 1472 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 783 | 0.080 |
Why?
|
| Rats | 5 | 2019 | 3735 | 0.070 |
Why?
|
| Animals, Genetically Modified | 2 | 2004 | 100 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 1596 | 0.060 |
Why?
|
| Cats | 1 | 2024 | 82 | 0.050 |
Why?
|
| Receptors, Glutamate | 1 | 2023 | 28 | 0.050 |
Why?
|
| Homozygote | 1 | 2023 | 77 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 247 | 0.050 |
Why?
|
| Escherichia coli Proteins | 1 | 2024 | 133 | 0.050 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 10 | 0.050 |
Why?
|
| Oxazines | 1 | 2021 | 32 | 0.040 |
Why?
|
| DNA Damage | 1 | 2024 | 356 | 0.040 |
Why?
|
| Pyridones | 1 | 2021 | 50 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2004 | 638 | 0.040 |
Why?
|
| Piperazines | 1 | 2021 | 120 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 592 | 0.040 |
Why?
|
| Macrophages | 1 | 2004 | 529 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 348 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 2014 | 258 | 0.040 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Tyrosine | 1 | 2019 | 120 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2018 | 26 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 40 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2018 | 52 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 44 | 0.040 |
Why?
|
| Lymphoma | 1 | 2018 | 41 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2018 | 91 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2018 | 158 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 57 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 206 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 1869 | 0.030 |
Why?
|
| DNA Repair | 1 | 2018 | 198 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 220 | 0.030 |
Why?
|
| Male | 4 | 2024 | 23409 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 75 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2016 | 54 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 72 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2016 | 92 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 81 | 0.030 |
Why?
|
| Humans | 4 | 2024 | 43102 | 0.030 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2014 | 4 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2014 | 1766 | 0.030 |
Why?
|
| Phylogeny | 1 | 2018 | 769 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2014 | 61 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 458 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 204 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1285 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 701 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 511 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1019 | 0.020 |
Why?
|
| Female | 2 | 2024 | 24698 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2004 | 165 | 0.010 |
Why?
|
| Captopril | 1 | 2003 | 6 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 210 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2003 | 86 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2003 | 321 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 934 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 712 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 287 | 0.010 |
Why?
|
| Age Factors | 1 | 2003 | 1154 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2003 | 666 | 0.010 |
Why?
|